Business Context and Reporting Period
This Form 6-K filing by Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) covers the period from August 17, 2026, to August 21, 2026. The report details the execution of the first tranche of a share buyback program approved by the Board of Directors on July 29, 2026, in compliance with EU market abuse regulations.
Key Financial Metrics
The filing focuses exclusively on capital allocation activities regarding the share repurchase program. It does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels.
- Total Shares Purchased (Aug 17-21): 5,798,862 shares
- Cash Amount Spent (First Tranche to Date): €390,930,519.33
- Program Utilization: Approximately 39.09% of the maximum cash amount allocated for the First Tranche.
- Trading Venues: Transactions occurred on AQEU, XMAD, CEUX, and TQEX.
Material Changes
The filing reports a material change in the company's capital structure through the reduction of outstanding shares. Between August 17 and August 21, 2026, BBVA executed significant purchases across multiple trading venues. The weighted average purchase prices ranged from approximately €24.59 to €25.06 during this specific window.
Guidance, Outlook, and Risks
The document contains no forward-looking guidance, management commentary on future earnings, or discussion of operational risks. The primary contingency noted is the ongoing execution of the buyback program, which is subject to market conditions and regulatory compliance. The filing explicitly states that the English version is a translation and the Spanish original prevails in case of discrepancy.
Investor Verification Checklist
- Verify the total maximum cash amount authorized for the First Tranche to confirm the remaining capacity (currently ~60.91% unused).
- Confirm the total number of shares repurchased to date against the company's total outstanding share count to assess dilution impact.
- Review the original Spanish filing for any nuances not captured in the English translation.
- Monitor subsequent filings for the completion of the First Tranche and potential approval of additional tranches.